These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21519254)

  • 1. Managing the risks of immunosuppression.
    Riminton DS; Hartung HP; Reddel SW
    Curr Opin Neurol; 2011 Jun; 24(3):217-23. PubMed ID: 21519254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic infections and other risks with newer multiple sclerosis therapies.
    Berger JR; Houff S
    Ann Neurol; 2009 Apr; 65(4):367-77. PubMed ID: 19399841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infections during Immunosuppression].
    Depmeier C; Günthard HF; Steiner UC
    Praxis (Bern 1994); 2018 Jun; 107(13):689-698. PubMed ID: 29921180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of reactivation or exacerbation of an infectious disease during iatrogenic immunosuppression or immune reconstitution].
    Bourgarit A; Lortholary O
    Rev Prat; 2011 Oct; 61(8):1051-5. PubMed ID: 22135964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution syndrome and fungal infections.
    Gupta AO; Singh N
    Curr Opin Infect Dis; 2011 Dec; 24(6):527-33. PubMed ID: 22025021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
    Vassilopoulos D; Calabrese LH
    Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimization of immunosuppression in kidney transplantation.
    Augustine JJ; Hricik DE
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Nervous System Infections With Immunomodulatory Therapies.
    Williamson EM; Berger JR
    Continuum (Minneap Minn); 2015 Dec; 21(6 Neuroinfectious Disease):1577-98. PubMed ID: 26633777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression.
    Ponticelli C
    Nephrol Dial Transplant; 2011 Jun; 26(6):1769-75. PubMed ID: 21482636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of travel-related infections in compromised hosts.
    McCarthy AE; Mileno MD
    Curr Opin Infect Dis; 2006 Oct; 19(5):450-5. PubMed ID: 16940868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of the immune reconstitution inflammatory syndrome.
    Meintjes G; Lynen L
    Curr Opin HIV AIDS; 2008 Jul; 3(4):468-76. PubMed ID: 19373007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The double-edged sword of statin immunomodulation.
    Goldstein MR; Mascitelli L; Pezzetta F
    Int J Cardiol; 2009 Jun; 135(1):128-30. PubMed ID: 18485499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety issues with biological therapies for inflammatory bowel disease.
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2006 Jul; 22(4):370-6. PubMed ID: 16760752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral infections in transplant recipients.
    Razonable RR; Eid AJ
    Minerva Med; 2009 Dec; 100(6):479-501. PubMed ID: 20010483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.